On May 20, 2024, Accelerate Diagnostics, Inc. closed the transaction. The company has now issued 2,716,763 units at a price of $1.73 per unit for the gross proceeds of $4,699,999.99 in the transaction. The company has issued 1,156,069 Units at a price of $1.73 per unit for gross proceeds of $2,700,000.62 in its second and final tranche closing.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 USD | +7.76% |
|
-6.72% | -68.11% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-68.11% | 29.51M | |
+4.98% | 213B | |
+7.44% | 184B | |
+28.22% | 153B | |
+33.19% | 113B | |
+1.22% | 63.66B | |
+16.51% | 53.53B | |
+1.45% | 49.11B | |
-4.53% | 38.73B | |
+2.74% | 36.26B |
- Stock Market
- Equities
- AXDX Stock
- News Accelerate Diagnostics, Inc.
- Accelerate Diagnostics, Inc. announced that it has received $4.7 million in funding from Jack W. Schuler Living Trust